Compare Grand House Mulia Tbk. (HOMI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Grand House Mulia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Grand House Mulia Tbk. trades at Rp206 (market cap 311.85B, 4.24M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Grand House Mulia Tbk. is the larger of the two by market cap, and Grand House Mulia Tbk. is more actively traded (4.24M versus 62.5K). Which is the better fit depends on your goals.
| HOMI | OBAT | |
|---|---|---|
Market Cap | 311.85B | 164.65B |
Volume | 4.24M | 62.5K |
Lot | 42.43K | 625 |
Turnover | 843.27M | 15.03M |
Average Price | 198.77 | 240.55 |
Value | 843.27M | 15.03M |
Indicative Equilibrium Price | 198 | 238 |
Indicative Equilibrium Volume | 39.3K | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Grand House Mulia Tbk.
PT Grand House Mulia, Tbk (“the Company”) was established in Republic of Indonesia based on the Notarial Deed No. 1 dated January 9, 2006 of Suryati Moerwibowo, S.H., The Company has commercially operated in April 2019.
Read more on HOMI →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
